193 related articles for article (PubMed ID: 23156085)
1. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
[TBL] [Abstract][Full Text] [Related]
3. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
[TBL] [Abstract][Full Text] [Related]
4. [Immune system disorders and their correction in critically ill patients with toxic and hypoxic encephalopathy].
Loladze A; Shilov V; Batotsyrenov B; Vasilyev S; Kuznetsov O
Georgian Med News; 2012 Feb; (203):17-22. PubMed ID: 22466535
[TBL] [Abstract][Full Text] [Related]
5. [Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning].
Klin Med (Mosk); 2011; 89(6):56-9. PubMed ID: 22420197
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
[TBL] [Abstract][Full Text] [Related]
7. [COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY].
Golub IY; Beloborodov VA; Sorokina LV; Kur'yanov AA; Borisova VM
Vestn Khir Im I I Grek; 2015; 174(4):53-5. PubMed ID: 26601519
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
9. [Correcting posthypoxic damage of myocardium in newborns with cerebral ischemia].
Degtiareva EA; Romantsov MG; Zhdanova OI; Mikheeva AA; Avakian AA
Eksp Klin Farmakol; 2010 Oct; 73(10):17-20. PubMed ID: 21254508
[TBL] [Abstract][Full Text] [Related]
10. [The use of cytoflavin in sports nutrition].
Kosinets VA; Stolbitskiĭ VV; Shturich IP
Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
Pochepen' ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910
[TBL] [Abstract][Full Text] [Related]
12. [Cytoflavin in total intravenous anesthesia].
Ovezov AM; Bragina SV; Prokoshev PV
Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
Beĭn BN; Dravert NE
Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products].
Shilov VV; Vasil'ev SA; Kuznetsov OA; Batotsyrenov BV; Loladze AT
Med Tr Prom Ekol; 2012; (6):22-7. PubMed ID: 22997755
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
Mikhaĭlova EV; Danilova AN; Chudakova TK; Romanovskaia AV; Dubovitskaia NA; Belova AE
Eksp Klin Farmakol; 2013; 76(8):43-6. PubMed ID: 24228490
[TBL] [Abstract][Full Text] [Related]
16. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759
[TBL] [Abstract][Full Text] [Related]
19. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
[TBL] [Abstract][Full Text] [Related]
20. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
